1. Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial. Issue 1 (January 2021) Authors: Goldman, Jonathan W; Dvorkin, Mikhail; Chen, Yuanbin; Reinmuth, Niels; Hotta, Katsuyuki; Trukhin, Dmytro; Statsenko, Galina; Hochmair, Maximilian J; Özgüroğlu, Mustafa; Ji, Jun Ho; Garassino, Marina Chiara; Voitko, Oleksandr; Poltoratskiy, Artem; Ponce, Santiago; Verderame, Francesco; Havel, Libo... Journal: Lancet oncology Issue: Volume 22:Issue 1(2021) Page Start: 51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Medical applications of mass spectrometry. (2011) Other Names: Vékey, Károly; Telekes, András; Vertes, Akos, 1952- Record Type: Book Extent: 1 online resource (606 pages) View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Simple correction improving long‐term reproducibility of HPLC–MS. (18th August 2015) Authors: Tóth, Eszter; Hevér, Helga; Ozohanics, Olivér; Telekes, András; Vékey, Károly; Drahos, László Journal: Journal of mass spectrometry Issue: Volume 50:Number 10(2015:Oct.) Page Start: 1130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Simple correction improving long‐term reproducibility of HPLC–MS. (18th August 2015) Authors: Tóth, Eszter; Hevér, Helga; Ozohanics, Olivér; Telekes, András; Vékey, Károly; Drahos, László Journal: Journal of mass spectrometry Issue: Volume 50:Number 10(2015:Oct.) Page Start: 1130 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗